Phase II Study of Pandemic Influenza Vaccine

NCT00320346 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Seqirus